Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research - «Национальный агрегатор открытых репозиториев российских университетов» (НОРА)

Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

расширенный поиск

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

Дата публикации: 2021-04-27

Дата публикации в реестре: 2021-10-05T18:23:50Z

Аннотация:

Ключевые слова:
acetylsalicylic acid, alteplase, angiotensin converting enzyme 2, antithrombin, danaparoid, dipyridamole, drotrecogin, glucocorticoid, hydroxychloroquine, immunoglobulin enhancer binding protein, interleukin 6, recombinant thrombomodulin, rivaroxaban, sulodexide, ticagrelor, tocilizumab, urokinase, von Willebrand factor, vorapaxar, anticoagulant agent, antiinflammatory agent, antithrombocytic agent, antivirus agent, fibrinolytic agent, glycosaminoglycan, sulodexide, activated partial thromboplastin time, acute coronary syndrome, adult respiratory distress syndrome, bleeding, clinical trial (topic), coronavirus disease 2019, cytokine release, human, immunomodulation, inflammation, mortality, nonhuman, platelet count, priority journal, Review, Severe acute respiratory syndrome coronavirus 2, thrombocyte aggregation, thromboinflammation, thromboinflammation, thrombosis, venous thromboembolism, animal, Betacoronavirus, complication, Coronavirus infection, hemostasis, immunology, inflammation, pandemic, thrombosis, virus pneumonia, Animals, Anti-Inflammatory Agents, Anticoagulants, Antiviral Agents, Betacoronavirus, Coronavirus Infections, Fibrinolytic Agents, Glycosaminoglycans, Hemostasis, Humans, Inflammation, Pandemics, Platelet Aggregation Inhibitors, Pneumonia, Viral, Thrombosis

Тип: info:eu-repo/semantics/journal-article

Связанные документы (рекомендация CORE)